Down-expressed GAS6-AS1 acted as a sponge for miR-24-3p and down-regulated the expression of its target, GTPase IMAP Family Member 6. These findings suggested that GAS6-AS1 might represent a potential diagnostic biomarker for LUAD.
Taken together, our results identified GAS6-AS1 as a novel tumor suppressor in LUAD and unraveled its underlying molecular mechanism in reprogramming glucose metabolism. GAS6-AS1 potentially may serve as a prognostic marker and therapeutic target in LUAD.
Mechanistically, Gas6 induced a competitive binding to phosphorylated signal transducers and activators of transcription 3 (STAT3) with large tumor suppressor kinase 1 (LATS1) and inhibited the Hippo pathway. This study revealed a novel non-transcriptional effect of STAT3 in Gas6/AXL-induced YAP activity, suggesting that STAT3 acted as a critical "molecular switch" during the mutual promotion between AXL and YAP, which might be a promising therapeutic target in HNSCC.
over 4 years ago
Journal
|
AXL (AXL Receptor Tyrosine Kinase) • STAT3 (Signal Transducer And Activator Of Transcription 3) • GAS6 (Growth arrest specific 6)
|
AXL expression • AXL overexpression • GAS6 overexpression
Treatment of BCa cells with SC79, an AKT activator, partially restored the effect of GAS6 silencing on cell proliferation and invasion. The present study suggests that GAS6 may play a pivotal role in the development of BCa and may be a potential target for its treatment.
over 4 years ago
Journal
|
AXL (AXL Receptor Tyrosine Kinase) • GAS6 (Growth arrest specific 6)